Company / Free Cash Flow
C4 Therapeutics, Inc. Free Cash Flow History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$99.3M
FY2025
5-year range
-$108.5M / -$88.2M
FY2022-FY2025
Trend
+8.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$109M to -$99M over the past 2 years.
Based on SEC 10-K filings.
-$99M in FY2025.
Improved from -$109M to -$99M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow increased 8.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$99.3M | +8.5% |
| FY2024 | -$108.5M | +0.0% |
| FY2023 | -$108.5M | -23.0% |
| FY2022 | -$88.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026